JP2025505738A5 - - Google Patents
Info
- Publication number
- JP2025505738A5 JP2025505738A5 JP2024547619A JP2024547619A JP2025505738A5 JP 2025505738 A5 JP2025505738 A5 JP 2025505738A5 JP 2024547619 A JP2024547619 A JP 2024547619A JP 2024547619 A JP2024547619 A JP 2024547619A JP 2025505738 A5 JP2025505738 A5 JP 2025505738A5
- Authority
- JP
- Japan
- Prior art keywords
- lag
- protein
- derivative
- subject
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2201803.0A GB202201803D0 (en) | 2022-02-11 | 2022-02-11 | Treatment of Cancer |
| GB2201803.0 | 2022-02-11 | ||
| GB2218181.2 | 2022-12-02 | ||
| GBGB2218181.2A GB202218181D0 (en) | 2022-12-02 | 2022-12-02 | Treatment of cancer |
| PCT/EP2023/053381 WO2023152335A1 (en) | 2022-02-11 | 2023-02-10 | Treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505738A JP2025505738A (ja) | 2025-02-28 |
| JP2025505738A5 true JP2025505738A5 (enExample) | 2026-02-19 |
Family
ID=85227021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547619A Pending JP2025505738A (ja) | 2022-02-11 | 2023-02-10 | がんの治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250368714A1 (enExample) |
| EP (1) | EP4475955A1 (enExample) |
| JP (1) | JP2025505738A (enExample) |
| KR (1) | KR20240149422A (enExample) |
| AU (1) | AU2023219133A1 (enExample) |
| CA (1) | CA3250299A1 (enExample) |
| IL (1) | IL314687A (enExample) |
| MX (1) | MX2024009818A (enExample) |
| WO (1) | WO2023152335A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025229157A1 (en) * | 2024-05-01 | 2025-11-06 | Immutep S.A.S. | Combination therapy using lag-3 protein and anti-pd-1 inhibitor with radiotherapy for treating cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2044949A1 (en) | 2007-10-05 | 2009-04-08 | Immutep | Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| EP4157313A1 (en) * | 2020-05-28 | 2023-04-05 | Immutep S.A.S. | Treatment of cancer |
-
2023
- 2023-02-10 AU AU2023219133A patent/AU2023219133A1/en active Pending
- 2023-02-10 WO PCT/EP2023/053381 patent/WO2023152335A1/en not_active Ceased
- 2023-02-10 IL IL314687A patent/IL314687A/en unknown
- 2023-02-10 US US18/837,252 patent/US20250368714A1/en active Pending
- 2023-02-10 KR KR1020247030427A patent/KR20240149422A/ko active Pending
- 2023-02-10 JP JP2024547619A patent/JP2025505738A/ja active Pending
- 2023-02-10 MX MX2024009818A patent/MX2024009818A/es unknown
- 2023-02-10 CA CA3250299A patent/CA3250299A1/en active Pending
- 2023-02-10 EP EP23704953.1A patent/EP4475955A1/en active Pending